Literature DB >> 5125476

Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.

W O Boggan, L S Seiden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5125476     DOI: 10.1016/0031-9384(71)90028-x

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


× No keyword cloud information.
  8 in total

1.  Central action of a catechol-amide seizure-inducing agent: opposing effect on tyrosine and tryptophan hydroxylase activity in vivo.

Authors:  C Kellogg; D Dobkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

2.  Monoamine effects on neuronal recovery cycles in globus pallidus, caudate nucleus, and substantia nigra.

Authors:  N Dafny; S Gilman
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

3.  Analysis of seizures induced by a catechol-derivative.

Authors:  C Kellogg; J LaMantia; J Jacobson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities.

Authors:  A R Cools; G Hendriks; J Korten
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

5.  Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.

Authors:  G M Anlezark; B S Meldrum
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

6.  Dopamine agonists and cobalt-induced epilepsy in the rat.

Authors:  I B Farjo; J K McQueen
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

7.  Increased paroxysmal activity of partial seizures in man by apomorphine.

Authors:  M Del Zompo; F Tocco; F Marrosu; N Passino; G U Corsini
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 8.  Pharmacological effects of phenylalanine on seizure susceptibility: an overview.

Authors:  P Y Sze
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.